The Phenotype of Circulating Follicular-Helper T Cells in Patients with Rheumatoid Arthritis Defines CD200 as a Potential Therapeutic Target
Figure 4
Relationship between CD200 expression on TFH cells, treatment, and disease activity. (a) The % of TFH cells expressing CD200 in patients being treated with anti-TNFα therapy was significantly increased compared with patients not on anti-TNFα therapy (). The mean DAS of patients receiving anti-TNFα therapy was 4.679, compared with 4.418 in patients who were not (). Each spot represents an individual patient, and the mean ± SEM are shown. (b) Correlation between TFH cell CD200 expression and DAS-28 score ().
